Similar Stories 🔰

Swelling in the body is often mistaken for weight gain, but experts warn it can be an early sign of kidney inflammation. Lifestyle factors like high salt intake, diabetes, and inactivity contribute to this condition. Early detection and lifestyle changes can help prevent serious kidney damage.

Semaglutide goes generic in India, cutting costs and expanding access. Here's what it means for diabetes and weight loss treatment.

While fasting blood sugar level is commonly checked to detect diabetes, it does not provide the most accurate reading, shares Dr Sudhir Kumar. | Health

With patent protection ending, Indian companies have moved quickly to introduce lower-cost versions with monthly therapy expected at around Rs 3,000 to Rs 4,000 for initial doses

A recent study has found that nearly 54% of patients with type 2 diabetes (T2D) suffer from fatty pancreas disease (FPD).

A doctor highlights how everyday biscuits, often paired with tea, may quietly drive insulin resistance. Made with refined flour, sugar and oils, they trigger repeated glucose spikes, leading to fatigue, hunger cycles and long-term metabolic issues, including type 2 diabetes.

India has been the world's diabetes capital for quite some time now. And according to experts, it stems from obesity. To make matters worse, obesity is now showing up in children at a relatively younger age. Here's what the World Obesity Atlas 2026 has found., Health, Times Now

New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug's patent expired, offering lower-cost options for patients managing Type 2 diabetes and obesity.

With the semaglutide patent expiring in India, multiple drugmakers have launched lower-cost versions of the diabetes and weight-loss treatment. Prices are expected to drop significantly, improving access but also raising concerns around misuse.

The researchers estimated that people with type 1 diabetes were nearly three times as likely to develop dementia as people without diabetes. People with type 2 diabetes were twice as likely to develop dementia as people without diabetes.